This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Juan Jose Perez Ruixo: Innovator in Cancer Treatment
Introduction
Juan Jose Perez Ruixo is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of cancer treatment, particularly through his innovative methods involving erdafitinib. His work is crucial in the ongoing battle against cancer, showcasing the potential of targeted therapies.
Latest Patents
Juan Jose Perez Ruixo holds a patent for a method of cancer treatment utilizing erdafitinib. This patent represents a significant advancement in therapeutic options for patients suffering from various forms of cancer. The innovative approach outlined in his patent aims to improve treatment efficacy and patient outcomes.
Career Highlights
Juan Jose Perez Ruixo is associated with Janssen Pharmaceutica NV, a leading pharmaceutical company known for its commitment to developing innovative healthcare solutions. His role at the company allows him to contribute to groundbreaking research and development in oncology.
Collaborations
Juan Jose has collaborated with esteemed colleagues such as Peter Marie Z De Porre and Arlene O Siefker-Radtke. These collaborations enhance the research efforts and bring diverse expertise to the development of cancer treatments.
Conclusion
Juan Jose Perez Ruixo's work in cancer treatment exemplifies the impact of innovation in medicine. His contributions through patents and collaborations are vital in advancing therapeutic options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile